The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
quinidine gluconate · Powder
3 marketed package NDCs · 1 active manufacturer
Most dispensed: 324 mg · Tablet, Extended Release · #100 tablet, extended releases/bottle, plastic
What changed in the last 90 days
Every detected change for quinidine gluconate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Quinidine GluconateAug 19, 2026Price downNADAC $5.10844 → $5.08826 per unit (-0.4%)
- Quinidine GluconateJul 22, 2026Price upNADAC $5.07009 → $5.10844 per unit (+0.76%)
Same drug class
Other molecules FDA puts in Cytochrome P450 2D6 Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Quinidine gluconate in shortage right now?
- No. FDA does not currently list Quinidine gluconate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Quinidine gluconate?
- 3 companies have marketed Quinidine gluconate in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
- What does Quinidine gluconate cost?
- The typical pharmacy pays about $5.09 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.